DGAP-News: Imcyse appoints new Scientific Advisory Board and opens new laboratories for next phase of growth boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
Pfizer takes equity stake in Imcyse as part of the recently announced Rheumatoid Arthritis license agreement Major existing shareholders participated in the round Proceeds to advance Imcyse’s pipeline of first-in-class targeted disease modifying immunotherapeutics Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of … Pfizer takes equity stake in Imcyse as part of the recently announced Rheumatoid Arthritis license agreement Major existing shareholders participated in the round Proceeds to advance Imcyse’s pipeline of first-in-class targeted disease modifying immunotherapeutics
Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of severe autoimmune diseases, today announced that it has concluded a Series B extension financing round, raising EUR 21.3 million (USD 25.8 milli
DGAP-News: Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder
vom 17.02.2021, 14:00 Uhr
Bild: pixabay.com
DGAP-News: Imcyse SA / Key word(s): Financing
Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder
17.02.2021 / 14:00
The issuer is solely responsible for the content of this announcement.
Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder
Pfizer takes equity stake in Imcyse as part of the recently announced Rheumatoid Arthritis license agreement
Major existing shareholders participated in the round
Proceeds to advance Imcyse s pipeline of first-in-class targeted disease modifying immunotherapeutics
Investegate |Imcyse SA Announcements | Imcyse SA: Imcyse Raises Additional EUR 21 3 Million in Series B Financing Round investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Hits: 1464
Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active, specific immunotherapies for the treatment of severe, chronic autoimmune diseases, today enters into Research Collaboration and License Agreement for its Imotope™ Technology with Pfizer in Rheumatoid Arthritis
• Imcyse and Pfizer to collaborate to develop Imotope™ candidates to potentially treat Rheumatoid Arthritis
• Pfizer to lead clinical development and commercialization activities
• Imcyse to receive upfront payment in cash and through the purchase of equity in addition to milestone up to $180 million and tiered royalty payments
LIEGE, Belgium I February 03, 2021 I Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of severe autoimmune diseases, today announced that it has entered into a research collaboration and license agreement with Pfi